Validation of Epidemiological Methods for Studying the Infection Risk in Rheumatoid Arthritis with Methotrexate Combined Biologicals using Propensity Scores

Takuma Koinuma, M. Akazawa
{"title":"Validation of Epidemiological Methods for Studying the Infection Risk in Rheumatoid Arthritis with Methotrexate Combined Biologicals using Propensity Scores","authors":"Takuma Koinuma, M. Akazawa","doi":"10.3820/jjpe.26.e3","DOIUrl":null,"url":null,"abstract":"Probability Weighting Estimator(IPW)and Augmented Inverse Probability Weighting Estimator(AIPW) analyses. Results :The Odds Ratios(OR)estimated by each method using the time axis of the elapsed time, the prescription number, and the administration time were 1.48(95%CI 0.71-3.11), 1.60(95%CI 0.72-3.55), and 1.04(95%CI 0.58-1.86), respectively. We performed PS weighting, of each Average Treatment Effect obtained from IPW, and the AIPW were estimated to be 0.31%(95%CI −0.91-1.53)and 0.29%(95%CI −0.91-1.49), respectively, and the average treatment effect on the treated was estimated to be 0.10% (95%CI −1.11-1.32). We support the findings of a previous study which showed that the combination of biologicals was not statistically associated with increased infection risk. Conclusion :This study suggests that estimators from different perspectives might be obtained by using some epidemiological methods. Therefore, our results could contribute to the establishment of an improved methodology.","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3820/jjpe.26.e3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Probability Weighting Estimator(IPW)and Augmented Inverse Probability Weighting Estimator(AIPW) analyses. Results :The Odds Ratios(OR)estimated by each method using the time axis of the elapsed time, the prescription number, and the administration time were 1.48(95%CI 0.71-3.11), 1.60(95%CI 0.72-3.55), and 1.04(95%CI 0.58-1.86), respectively. We performed PS weighting, of each Average Treatment Effect obtained from IPW, and the AIPW were estimated to be 0.31%(95%CI −0.91-1.53)and 0.29%(95%CI −0.91-1.49), respectively, and the average treatment effect on the treated was estimated to be 0.10% (95%CI −1.11-1.32). We support the findings of a previous study which showed that the combination of biologicals was not statistically associated with increased infection risk. Conclusion :This study suggests that estimators from different perspectives might be obtained by using some epidemiological methods. Therefore, our results could contribute to the establishment of an improved methodology.
使用倾向评分研究类风湿关节炎甲氨蝶呤联合生物制剂感染风险的流行病学方法的验证
概率加权估计(IPW)和增广逆概率加权估计(AIPW)分析。结果:采用时间轴、处方数、给药时间估算的比值比(OR)分别为1.48(95%CI 0.71 ~ 3.11)、1.60(95%CI 0.72 ~ 3.55)、1.04(95%CI 0.58 ~ 1.86)。我们对从IPW中获得的每个平均处理效果进行PS加权,估计AIPW分别为0.31%(95%CI−0.91-1.53)和0.29%(95%CI−0.91-1.49),对被处理者的平均处理效果估计为0.10% (95%CI−1.11-1.32)。我们支持先前的一项研究结果,该研究表明生物制剂的组合与感染风险增加没有统计学关联。结论:采用不同的流行病学方法,可以得到不同角度的估计值。因此,我们的结果可能有助于建立一种改进的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信